BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3479520)

  • 21. [Age-related working memory decline in patients with Parkinson's disease].
    Tamura I; Kikuchi S; Kitagawa M; Otsuki M; Tashiro K
    No To Shinkei; 2003 Apr; 55(4):335-40. PubMed ID: 12755037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissociation between spontaneous and reactive flexibility in early Parkinson's disease.
    Tomer R; Fisher T; Giladi N; Aharon-Peretz J
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Jun; 15(2):106-12. PubMed ID: 12050473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of neuropsychological performance according to the age of onset in subjects with Parkinson's disease and Parkinsonism].
    Ruiz-Rizzo AL; Tirado V; Moreno-Carrillo C; Aguirre-Acevedo DC; Murillo O; Lopera F
    Rev Neurol; 2009 Aug 1-15; 49(3):123-30. PubMed ID: 19621306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease.
    McKinlay A; Grace RC; Dalrymple-Alford JC; Roger D
    Dement Geriatr Cogn Disord; 2009; 28(2):121-9. PubMed ID: 19690414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of acute tryptophan depletion on cognition, memory and motor performance in Parkinson's disease.
    Scholtissen B; Verhey FR; Adam JJ; Prickaerts J; Leentjens AF
    J Neurol Sci; 2006 Oct; 248(1-2):259-65. PubMed ID: 16756999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Explicit and implicit learning in patients with Alzheimer disease and Parkinson disease with dementia.
    Kuzis G; Sabe L; Tiberti C; Merello M; Leiguarda R; Starkstein SE
    Neuropsychiatry Neuropsychol Behav Neurol; 1999 Oct; 12(4):265-9. PubMed ID: 10527111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.
    Roizen N; Kasza K; Karrison T; Mets M; Noble AG; Boyer K; Swisher C; Meier P; Remington J; Jalbrzikowski J; McLeod R; Kipp M; Rabiah P; Chamot D; Estes R; Cezar S; Mack D; Pfiffner L; Stein M; Danis B; Patel D; Hopkins J; Holfels E; Stein L; Withers S; Cameron A; Perkins J; Heydemann P
    Pediatrics; 2006 Aug; 118(2):e379-90. PubMed ID: 16864640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholinergic deficiency and frontal dysfunction in Parkinson's disease.
    Dubois B; Pilon B; Lhermitte F; Agid Y
    Ann Neurol; 1990 Aug; 28(2):117-21. PubMed ID: 2221841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
    Huguelet P; Nicastro R; Zanello A
    Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive decline in Parkinson's disease: a prospective longitudinal study.
    Muslimović D; Post B; Speelman JD; De Haan RJ; Schmand B
    J Int Neuropsychol Soc; 2009 May; 15(3):426-37. PubMed ID: 19402929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Verbal fluency deficits in Parkinson's disease: a meta-analysis.
    Henry JD; Crawford JR
    J Int Neuropsychol Soc; 2004 Jul; 10(4):608-22. PubMed ID: 15327739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of pallidotomy and bilateral subthalamic stimulation on cognitive function in Parkinson disease. A controlled comparative study.
    Gironell A; Kulisevsky J; Rami L; Fortuny N; García-Sánchez C; Pascual-Sedano B
    J Neurol; 2003 Aug; 250(8):917-23. PubMed ID: 12928909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive dysfunctions in mild Parkinson's disease dementia: comparison with patients having mild Alzheimer's disease and normal controls.
    Song IU; Kim JS; Yoo JY; Song HJ; Lee KS
    Eur Neurol; 2008; 59(1-2):49-54. PubMed ID: 17917458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical heterogeneity in Parkinson's disease revisited: a latent profile analysis.
    Flensborg Damholdt M; Shevlin M; Borghammer P; Larsen L; Ostergaard K
    Acta Neurol Scand; 2012 May; 125(5):311-8. PubMed ID: 21707551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intellectual impairments in patients with Parkinson's disease--a proposal of the subgroups of the disease].
    Nishimatsu O; Horiguchi J; Inami Y; Sukegawa T; Shoda M
    Rinsho Shinkeigaku; 1989 Oct; 29(10):1216-20. PubMed ID: 2605826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visuospatial working memory in Parkinson's disease.
    Bradley VA; Welch JL; Dick DJ
    J Neurol Neurosurg Psychiatry; 1989 Nov; 52(11):1228-35. PubMed ID: 2592967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visuospatial impairment in Parkinson's disease: the role of laterality.
    Karádi K; Lucza T; Aschermann Z; Komoly S; Deli G; Bosnyák E; Acs P; Horváth R; Janszky J; Kovács N
    Laterality; 2015; 20(1):112-27. PubMed ID: 25341015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using executive heterogeneity to explore the nature of working memory deficits in Parkinson's disease.
    Lewis SJ; Cools R; Robbins TW; Dove A; Barker RA; Owen AM
    Neuropsychologia; 2003; 41(6):645-54. PubMed ID: 12591022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Digit Ordering Test: clinical, psychometric, and experimental evaluation of a verbal working memory test.
    Hoppe CD; Müller UD; Werheid KD; Thöne AD; von Cramon YD
    Clin Neuropsychol; 2000 Feb; 14(1):38-55. PubMed ID: 10855058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.